Group 1 - Medline plans to raise up to $5.37 billion through an IPO, with a target valuation of $55.3 billion, making it potentially the largest IPO in the U.S. for 2025 [1] - The company intends to issue 179 million shares at an estimated price range of $26 to $30 per share [1] - The upcoming IPO is expected to be a significant event in the market, serving as a key indicator of investor sentiment as it approaches 2026 [1] Group 2 - Medline is one of the largest manufacturers and distributors of medical supplies in the U.S., providing surgical and procedural packs, gloves, and protective clothing used in hospitals and nursing homes worldwide [1]